Showing results (291-300 of 482) with videos related to

Sort By:
Pageof 49
Journal for Immunotherapy of Cancer|July 26, 2024
Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapyHaider Al-Janabi, Katy Moyes, Richard Allen, et al.
International Journal of Cancer|December 16, 2017
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistanceClaire A Martin, Carleen Cullinane, Laura Kirby, et al.
Cancer Discovery|May 17, 2019
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation StudyAmit Khot, Natalie Brajanovski, Donald P Cameron, et al.
Cancer Discovery|October 23, 2015
Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven LymphomaJennifer R Devlin, Katherine M Hannan, Nadine Hein, et al.
Cells|April 26, 2024
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate CancerDaniel J Turnham, Manisha S Mullen, Nicholas P Bullock, et al.
Oncotarget|October 27, 2017
[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivoAna Carolina B M Martin, Angelina M Fuzer, Amanda B Becceneri, et al.
Molecular Cancer Therapeutics|August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP InhibitionMitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
The EMBO Journal|September 18, 2020
Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesisEric P Kusnadi, Anna S Trigos, Carleen Cullinane, et al.
Nature Communications|May 15, 2023
Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironmentsYuzhou Feng, Tianpei Yang, John Zhu, et al.
Science Signaling|August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanomaRachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.
Pageof 49